Price increase is a victory for shareholders who had objected to the original offer
Top-five shareholder becomes latest big City investor to criticise buyouts of UK listed companies
Pushing for a higher price would be the right course of treatment
2015 was overall an encouraging year for my portfolio
All-cash pharmaceuticals deal is second European move in weeks
Latest directors’ deals at Daily Internet, Personal Assets, IG Group, UDG Healthcare and Asos
Portfolio hit by listless share prices
With the FTSE 100 index up just 2 per cent so far this year, our columnists have made a slow start to the year
This is the most frequent complaint from small-cap chief executives – and, in the case of Laurence Orbach of Quarto, it’s a fair point
The story of Boots has warnings for foreign acquirers
